Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02470494Not ApplicableCompleted

The EarLens Contact Hearing Device (CHD) Spectrum Study

Role: lead

NCT00582946Phase 1Completed

Wide-Bandwidth Open Canal Hearing Aid For Better Multitalker Speech Understanding

Role: lead

NCT02042404Not ApplicableCompleted

The EarLens System Long Term Safety and Efficacy Definitive Multi-Center Study

Role: lead

All 3 trials loaded